AACCE Investments
ScreenerStocksIndicesPicksETFsBlogPricing

© 2026 ACCE Investments. All rights reserved.

ACCE Investments - Institutional-grade stock research for retail investors | BetaList
IndicesStocksETFsScreenerBlogGlossaryCompareMarket dataAdvisors
TermsPrivacyCookiesDisclaimerLegal noticeProfessional termsAboutContact
4183.T

Mitsui Chemicals, Inc. (4183.T) fair value

Basic Materials · Specialty Chemicals · TSE · Japan
¥2063.00+0.34%
Market cap ¥745.9BNext earnings 2026-11-11Updated Oct 24, 2026 · valuation updating
Our verdict
No fair value
We are missing the financial data our models need for this company. It will appear once the data arrives.
Not valued: there are no financial statements on file yet.
ACCE opinionMitsui Chemicals, Inc. (4183.T)
Fair value
Not available
ACCE price target
¥2250
Rating
Not rated
Horizon
12 months
ACCE price target published on 23 Oct 2026, 01:53 CEST.
Price used: ¥2063 at the close on 23 Oct 2026, 08:30 CEST.
Fair value: the average of the applicable valuation models (discounted cash flow, multiples, residual income, dividend discount, shareholder yield), each run on the latest financial statements and the market price shown. Opinion columns (fair value, target, rating) are shown apart from the data. Full methodology: acceinvestments.com/data/how-we-value-stocks
Full methodology
Conflicts of interest: The author holds no personal position in this security. General statement
Produced by ACCE Investments (acceinvestments.com)
Data
ACCE score
64
out of 100
P/E
11.5x
forward 4.5x
1-year return
+10.6%
Dividend yield
3.65%

Mitsui Chemicals, Inc. in four questions

Plain answers, details below
Free accounts get 5 full stock pages a month, including the four answers.
OverviewAsk ACCEValuationQualityAnalystsSmart MoneyCompareNews and Record

Overview

ACCE thesis

Mitsui Chemicals makes performance materials (engineering plastics, polyurethane and elastomers used in automotive parts and electronics), basic chemicals such as phenol and ammonia, and agrochemicals and crop protection products. The business has grown revenue 10.8% over the latest reported year, with a 23.5% gross margin and a 9.0% operating margin, which points to a mix that has moved toward higher-value specialty lines. Its earnings are cyclical and tied to global auto and electronics demand, so the case rests on whether that mix shift holds through the cycle rather than on a single product wave. At 11.7 trailing and 4.5 forward earnings, the market is pricing in a sharp earnings recovery or doubting the durability of the current profit level; that gap is what merits a closer look at the forecasts and at returns on capital, since ROE of 8.0% is modest for the multiple implied.

AI-assisted·How I use AIWritten Oct 23, 2026

Walk me through this stock

Plain-English pros, cons, and what to watch. Pro feature.

PRO

Ask ACCE

Valuation

INVESTOR
Where 4183.T's valuation models land
Price
¥2063.00
Create a free account: 5 full stock pages a month, no card.

See what each model says, the assumptions behind it, the bad, normal and good cases, and why the fair value changed.

Quality

INVESTOR
Quality and conviction INVESTOR FEATURE

The full quality picture: a reason under every score, how the scores moved, and the conviction breakdown.

  • +A plain reason under every score
  • +Conviction breakdown and growth / value / quality / momentum scores
  • +Score history: how each score moved over time

Analysts

Wall Street consensus

No analyst coverage yet.
Analyst intelligence INVESTOR FEATURE

The full analyst picture: the price-target distribution against the current price, forward consensus estimates, and how ACCE's own models compare.

  • +Price-target low / average / high vs the current price, with implied upside
  • +Forward revenue and EPS consensus by fiscal year
  • +ACCE fair-value models lined up against the Street

Smart Money

PRO

In one line

Trades are only made public after a delay. We show the delay so you know how old the news is.

Company insiders
No trades filed
Last 90 days
Congress
No trades filed
Last 180 days
Average delay
No trades filed
From trade to public filing
Do politicians beat the market? Our backtest →
Smart money tracking PRO FEATURE

Follow the informed money: 13F position changes, insider and Congress trades, and 13D activist filings.

  • +Quarter-over-quarter institutional position changes
  • +Every insider and Congress trade, with how late it was disclosed
  • +Active 13D activist filings and top holders

Compare

Where it sits vs peers

News and Record

Recent performance

1 week
-1.9%
1 month
-5.6%
3 months
-5.0%
6 months
+9.2%
YTD
+3.0%
1 year
+10.6%

Recommendation history, last 12 months

DateTypeNewPreviousPrice
23 Oct 2026, 01:53 CESTACCE price target¥2250first publication¥2056

This analysis is not personalised investment advice and does not take your situation, objectives or risk tolerance into account. ACCE Investments is not an authorised investment firm.

Investing in shares carries a risk of losing capital. The value of an investment can go down as well as up.

This security trades in JPY. Exchange-rate movements can increase or reduce the result in your own currency.

Valuation horizon: 12 months from the publication date.

Conflicts of interest. ACCE Investments is operated by Adrien Chantreuil, who may hold personal positions in the securities analysed. Positions are declared on each security. ACCE receives no payment from the companies analysed or from any intermediary for this analysis.

Get the full 4183.T page, free

Every model, the scenarios, fair value history, AI notes and the four questions. 5 full stock pages every month on the free plan, no card.

Free accounts get 5 full stock pages a month, including the full page.

Snapshot

Growth76Value80Quality47Momentum54Total64
Valuation
Trailing P/E
11.5x
Forward P/E
4.5x
PEG
0.00
P/B
no data
EV / Revenue
no data
Book value/sh
no data
Enterprise value
no data
Profitability
ROE
8.0%
FCF yield
-0.79%
ROIC
no data
Health and risk
Debt / equity
0.82
Dividend yield
3.65%
Beta
no data

Price

+9.4% · 1Y

Ask anything about 4183.T

Answered from Mitsui Chemicals, Inc. fundamentals + recent valuations. Every number shows its source and date.

This stock Peer Peer median weaker → stronger
P/Ebetter than 100% of peers
low 11.5x11.5xhigh 89.3x
ROEbetter than 67% of peers
low -15%8%high 14%
Div yieldbetter than 100% of peers
low 0.1%3.6%high 3.6%

Peers

Prices Oct 23, 2026
CompanyPriceFair valuevs fair valueP/EROEQualityScore
4183.T Mitsui Chemicals, Inc.¥2063.00--11.5x8.0%4764
FLUOROCHEM.NS Gujarat Fluorochemicals Limited₹4303.90--76.1x-8166
4182.T Mitsubishi Gas Chemical Company, Inc.¥3539.00----3.4%4062
LINDEINDIA.NS Linde India Limited₹5900.50--89.3x-8944
4203.T Sumitomo Bakelite Company Limited¥7788.00--21.7x-7175
4403.T NOF Corporation¥2822.00--16.5x13.8%7562
4088.T Air Water Inc.¥2642.00--15.6x-15.3%3167

Sector report card

Where 4183.T ranks against its sector peers on each metric.

Computing percentiles…